Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Pinese

Showing results (51-60 of 63) with videos related to

Pageof 7
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 27, 2013
Histomolecular phenotypes and outcome in adenocarcinoma of the ampulla of vaterDavid K Chang, Nigel B Jamieson, Amber L Johns, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2026
Integrated germline and somatic molecular profiling to detect cancer predisposition has a high clinical impact in poor-prognosis paediatric cancerNoemi A Fuentes-Bolanos, Eliza Courtney, Chelsea Mayoh, et al.
Science Translational Medicine|April 7, 2017
Transient tissue priming via ROCK inhibition uncouples pancreatic cancer progression, sensitivity to chemotherapy, and metastasisClaire Vennin, Venessa T Chin, Sean C Warren, et al.
Nature Medicine|October 6, 2020
Whole genome, transcriptome and methylome profiling enhances actionable target discovery in high-risk pediatric cancerMarie Wong, Chelsea Mayoh, Loretta M S Lau, et al.
EMBO Molecular Medicine|December 20, 2021
In vitro and in vivo drug screens of tumor cells identify novel therapies for high-risk child cancerLoretta M S Lau, Chelsea Mayoh, Jinhan Xie, et al.
Annals of Neurology|January 24, 2025
Congenital Titinopathy: Comprehensive Characterization of the Most Severe End of the Disease SpectrumSandra Coppens, Nicolas Deconinck, Patricia Sullivan, et al.
Science Advances|March 12, 2025
Targeting the NPY/NPY1R signaling axis in mutant p53-dependent pancreatic cancer impairs metastasisCecilia R Chambers, Supitchaya Watakul, Peter Schofield, et al.
Nature|February 27, 2015
Whole genomes redefine the mutational landscape of pancreatic cancerNicola Waddell, Marina Pajic, Ann-Marie Patch, et al.
Gastroenterology|November 19, 2016
Hypermutation In Pancreatic CancerJeremy L Humphris, Ann-Marie Patch, Katia Nones, et al.
Nature|September 28, 2017
Corrigendum: Whole-genome landscape of pancreatic neuroendocrine tumoursAldo Scarpa, David K Chang, Katia Nones, et al.
Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 27, 2013
Histomolecular phenotypes and outcome in adenocarcinoma of the ampulla of vaterDavid K Chang, Nigel B Jamieson, Amber L Johns, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2026
Integrated germline and somatic molecular profiling to detect cancer predisposition has a high clinical impact in poor-prognosis paediatric cancerNoemi A Fuentes-Bolanos, Eliza Courtney, Chelsea Mayoh, et al.
Science Translational Medicine|April 7, 2017
Transient tissue priming via ROCK inhibition uncouples pancreatic cancer progression, sensitivity to chemotherapy, and metastasisClaire Vennin, Venessa T Chin, Sean C Warren, et al.
Nature Medicine|October 6, 2020
Whole genome, transcriptome and methylome profiling enhances actionable target discovery in high-risk pediatric cancerMarie Wong, Chelsea Mayoh, Loretta M S Lau, et al.
EMBO Molecular Medicine|December 20, 2021
In vitro and in vivo drug screens of tumor cells identify novel therapies for high-risk child cancerLoretta M S Lau, Chelsea Mayoh, Jinhan Xie, et al.
Annals of Neurology|January 24, 2025
Congenital Titinopathy: Comprehensive Characterization of the Most Severe End of the Disease SpectrumSandra Coppens, Nicolas Deconinck, Patricia Sullivan, et al.
Science Advances|March 12, 2025
Targeting the NPY/NPY1R signaling axis in mutant p53-dependent pancreatic cancer impairs metastasisCecilia R Chambers, Supitchaya Watakul, Peter Schofield, et al.
Nature|February 27, 2015
Whole genomes redefine the mutational landscape of pancreatic cancerNicola Waddell, Marina Pajic, Ann-Marie Patch, et al.
Gastroenterology|November 19, 2016
Hypermutation In Pancreatic CancerJeremy L Humphris, Ann-Marie Patch, Katia Nones, et al.
Nature|September 28, 2017
Corrigendum: Whole-genome landscape of pancreatic neuroendocrine tumoursAldo Scarpa, David K Chang, Katia Nones, et al.
Pageof 7